Breaking News Instant updates and real-time market news.

PEYUF

Peyto Exploration

$0.00 /

+ (+0.00%)

12:40
03/13/20
03/13
12:40
03/13/20
12:40

Peyto Exploration downgraded to Hold from Buy at TD Securities

TD Securities analyst Aaron Bilkoski downgraded Peyto Exploration to Hold from Buy with a price target of C$1.15, down from C$4.25. The analyst believes a material dividend cut or suspension is likely for Peyto, and noted that the firm updated its commodity price assumptions significantly downward.

PEYUF Peyto Exploration
$0.00 /

+ (+0.00%)

03/10/20 Canaccord
Peyto Exploration downgraded to Hold from Buy at Canaccord
04/11/19 Macquarie
Peyto Exploration upgraded to Neutral from Underperform at Macquarie

TODAY'S FREE FLY STORIES

Upgrade
Imperial Brands upgraded to Outperform from Sector Perform at RBC Capital » 06:17
09/22/20
09/22
06:17
09/22/20
06:17
IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

05:17 Today RBC Capital
Imperial Brands upgraded to Outperform from Sector Perform at RBC Capital
09/04/20 JPMorgan
Imperial Brands upgraded to Overweight from Neutral at JPMorgan
07/09/20 UBS
Imperial Brands price target raised to 1,460 GBp from 1,200 GBp at UBS
07/07/20 Morgan Stanley
Imperial Brands price target lowered to 1,593 GBp at Morgan Stanley
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

Initiation
NextEra Energy initiated with a Buy at Seaport Global » 06:16
09/22/20
09/22
06:16
09/22/20
06:16
NEE

NextEra Energy

$276.29 /

-0.6 (-0.22%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

09/15/20 BMO Capital
NextEra Energy price target raised to $293 from $286 at BMO Capital
09/15/20 Wells Fargo
Wells Fargo upgrades NextEra Energy Partners on renewables outlook
09/04/20 Atlantic Equities
NextEra Energy initiated with an Overweight at Atlantic Equities
09/01/20 Wells Fargo
NextEra Energy price target raised to $335 from $330 at Wells Fargo
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

Recommendations
Peloton shares have path to $175, says Roth Capital » 06:15
09/22/20
09/22
06:15
09/22/20
06:15
PTON

Peloton

$94.79 /

+5.005 (+5.57%)

Roth Capital analyst…

Roth Capital analyst George Kelly sees a path for Peloton Interactive shares to reach to $175 and he remains a buyer of the stock following the recent rally. Peloton closed Monday up $5.10 to $94.80. Sustained "rapid" revenue growth and "soon-to-come margin" expansion will give the stock support, Kelly tells investors in a research note. The analyst maintains a Buy rating on Peloton with a $125 price target. Several factors will drive sustained revenue growth in the coming years for Peloton, including continued at-home fitness momentum, new products, and lower prices, says Kelly. As a result, the analyst sees near-term upside and a $175 share price in four years.

ShowHide Related Items >><<
PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
09/16/20 Canaccord
Peloton on its way to connected fitness leadership, says Canaccord
09/16/20 Rosenblatt
Apple entrance not barrier to Peloton's growth, says Rosenblatt
09/16/20 Stifel
Peloton valuation framework supports 'four-year double,' says Stifel
PTON Peloton
$94.79 /

+5.005 (+5.57%)

  • 26
    Sep
PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

Downgrade
BioLife Solutions downgraded to Perform from Outperform at Oppenheimer » 06:14
09/22/20
09/22
06:14
09/22/20
06:14
BLFS

BioLife Solutions

$26.39 /

-0.79 (-2.91%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

09/18/20 Cowen
BioLife Solutions initiated with an Outperform at Cowen
08/11/20 Benchmark
BioLife Solutions downgraded at Benchmark as shares reach price target
08/11/20 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

  • 02
    Jul
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

Downgrade
CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
CTMX

CytomX Therapeutics

$6.94 /

-0.43 (-5.83%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

09/15/20 Citi
CytomX Therapeutics price target lowered to $8.50 from $11 at Citi
06/01/20 Jefferies
Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold
06/01/20 Jefferies
CytomX Therapeutics downgraded to Hold from Buy at Jefferies
05/29/20 Piper Sandler
CytomX ASCO data sets point torwards Probody validation, says Piper Sandler
CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

Downgrade
Eidos Therapeutics downgraded to Neutral from Buy at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
EIDX

Eidos Therapeutics

$47.62 /

-5.31 (-10.03%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

09/08/20 Citi
Eidos Therapeutics initiated with a Buy at Citi
06/05/20 Mizuho
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral on timeline delays at JPMorgan
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral from Overweight at JPMorgan
EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

Upgrade
Portland General Electric upgraded to Buy from Neutral at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
POR

Portland General Electric

$34.24 /

-0.77 (-2.20%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

09/21/20 Mizuho
Mizuho upgrades Portland General to Buy on valuation after selloff
09/21/20 Barclays
Portland General Electric upgraded to Equal Weight from Underweight at Barclays
09/21/20 Mizuho
Portland General Electric upgraded to Buy from Neutral at Mizuho
09/16/20 BofA
Portland General Electric upgraded to Buy from Neutral at BofA
POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

Recommendations
Seattle Genetics price target raised to $200 from $185 at JMP Securities » 06:11
09/22/20
09/22
06:11
09/22/20
06:11
SGEN

Seattle Genetics

$178.83 /

-2.33 (-1.29%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

Initiation
CF Bankshares initiated with a Neutral at Piper Sandler » 06:10
09/22/20
09/22
06:10
09/22/20
06:10
CFBK

CF Bankshares

$11.68 /

+ (+0.00%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFBK CF Bankshares
$11.68 /

+ (+0.00%)

Downgrade
Illumina downgraded to Neutral from Buy at UBS » 06:08
09/22/20
09/22
06:08
09/22/20
06:08
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

UBS analyst Dan Brennan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
05:02 Today Piper Sandler
Piper stays on sidelines after Illumina acquisition of Grail
09/21/20 JPMorgan
Illumina downgraded to Neutral after deal for Grail at JPMorgan
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Recommendations
Accenture price target raised to $229 from $206 at Piper Sandler » 06:08
09/22/20
09/22
06:08
09/22/20
06:08
ACN

Accenture

$233.94 /

-2.17 (-0.92%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
09/21/20 Barclays
Accenture price target raised to $260 from $240 at Barclays
09/20/20 Citi
Accenture price target raised to $269 from $247 at Citi
09/17/20 Stifel
Accenture price target raised to $270 from $236 at Stifel
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

Periodicals
DOJ to brief state AGs on Google antitrust suit, Washington Post reports » 06:07
09/22/20
09/22
06:07
09/22/20
06:07
GOOG

Alphabet

$1,429.64 /

-29.72 (-2.04%)

, GOOGL

Alphabet Class A

$1,429.51 /

-21.58 (-1.49%)

The DOJ is expected to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,429.64 /

-29.72 (-2.04%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

GOOG Alphabet
$1,429.64 /

-29.72 (-2.04%)

09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
08/12/20 JPMorgan
Broadcom likely co-designed Google's next-gen AI chip, says JPMorgan
GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
GOOG Alphabet
$1,429.64 /

-29.72 (-2.04%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

GOOG Alphabet
$1,429.64 /

-29.72 (-2.04%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

GOOG Alphabet
$1,429.64 /

-29.72 (-2.04%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

GOOGL Alphabet Class A
$1,429.51 /

-21.58 (-1.49%)

Downgrade
Kratos Defense downgraded to Neutral on valuation at JPMorgan » 06:07
09/22/20
09/22
06:07
09/22/20
06:07
KTOS

Kratos Defense

$19.75 /

-1.19 (-5.68%)

JPMorgan analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

04:49 Today JPMorgan
Kratos Defense downgraded to Neutral from Overweight at JPMorgan
08/03/20 Canaccord
Kratos Defense second half catalysts should support shares. says Canaccord
07/24/20 Benchmark
Kratos Defense price target raised to $26 from $19 at Benchmark
07/20/20 Baird
Kratos Defense designated a Fresh Pick at Baird
KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

  • 19
    Jun
KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

KTOS Kratos Defense
$19.75 /

-1.19 (-5.68%)

Upgrade
JPMorgan upgrades 'relatively resilient' CACI to Overweight » 06:05
09/22/20
09/22
06:05
09/22/20
06:05
CACI

CACI

$215.30 /

-3.18 (-1.46%)

JPMorgan analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CACI CACI
$215.30 /

-3.18 (-1.46%)

CACI CACI
$215.30 /

-3.18 (-1.46%)

04:49 Today JPMorgan
CACI upgraded to Overweight from Neutral at JPMorgan
08/14/20 Stifel
CACI price target raised to $300 from $295 at Stifel
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Raymond James
CACI downgraded to Market Perform from Outperform at Raymond James
CACI CACI
$215.30 /

-3.18 (-1.46%)

CACI CACI
$215.30 /

-3.18 (-1.46%)

CACI CACI
$215.30 /

-3.18 (-1.46%)

Hot Stocks
Vubiquity announces partnership with the Liberty Global group » 06:04
09/22/20
09/22
06:04
09/22/20
06:04
DOX

Amdocs

$58.25 /

+0.24 (+0.41%)

Vubiquity, part of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$58.25 /

+0.24 (+0.41%)

DOX Amdocs
$58.25 /

+0.24 (+0.41%)

02/05/20 Oppenheimer
Amdocs price target raised to $85 from $77 at Oppenheimer
11/15/19 Stifel
Amdocs price target raised to $75 from $70 at Stifel
DOX Amdocs
$58.25 /

+0.24 (+0.41%)

DOX Amdocs
$58.25 /

+0.24 (+0.41%)

Hot Stocks
Farmmi subsidiary passes HACCP certification audits » 06:03
09/22/20
09/22
06:03
09/22/20
06:03
FAMI

Farmmi

$0.91 /

+0.0125 (+1.39%)

Farmmi announced one of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FAMI Farmmi
$0.91 /

+0.0125 (+1.39%)

Downgrade
UniCredit downgraded to Neutral from Outperform at Credit Suisse » 06:03
09/22/20
09/22
06:03
09/22/20
06:03
UNCFF

UniCredit

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNCFF UniCredit
$0.00 /

+ (+0.00%)

05:07 Today Credit Suisse
UniCredit downgraded to Neutral from Outperform at Credit Suisse
09/10/20 HSBC
UniCredit downgraded to Hold from Buy at HSBC
09/10/20 HSBC
UniCredit downgraded to Hold from Buy at HSBC
08/27/20 Berenberg
UniCredit price target raised to EUR 9.50 from EUR 9 at Berenberg
UNCFF UniCredit
$0.00 /

+ (+0.00%)

Hot Stocks
Tutor Perini awarded $47M task order » 06:02
09/22/20
09/22
06:02
09/22/20
06:02
TPC

Tutor Perini

$11.20 /

-1.39 (-11.04%)

Tutor Perini announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPC Tutor Perini
$11.20 /

-1.39 (-11.04%)

TPC Tutor Perini
$11.20 /

-1.39 (-11.04%)

07/30/20 B. Riley FBR
Tutor Perini price target raised to $20 from $18 at B. Riley FBR
02/28/20 DA Davidson
DA Davidson skeptical Tutor Perini CEO would look to sell
02/27/20 DA Davidson
Tutor Perini price target lowered to $18 from $22 at DA Davidson
11/07/19 B. Riley FBR
Tutor Perini price target raised to $23 from $18 at B. Riley FBR
TPC Tutor Perini
$11.20 /

-1.39 (-11.04%)

TPC Tutor Perini
$11.20 /

-1.39 (-11.04%)

Upgrade
Leidos upgraded to Overweight on bottomed estimates at JPMorgan » 06:02
09/22/20
09/22
06:02
09/22/20
06:02
LDOS

Leidos

$88.37 /

-1.63 (-1.81%)

JPMorgan analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$88.37 /

-1.63 (-1.81%)

LDOS Leidos
$88.37 /

-1.63 (-1.81%)

04:49 Today JPMorgan
Leidos upgraded to Overweight from Neutral at JPMorgan
08/06/20 Stifel
Leidos share price reaction to earnings report 'puzzling,' says Stifel
06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
LDOS Leidos
$88.37 /

-1.63 (-1.81%)

LDOS Leidos
$88.37 /

-1.63 (-1.81%)

LDOS Leidos
$88.37 /

-1.63 (-1.81%)

Initiation
Intesa Sanpaolo reinstated with an Outperform at Credit Suisse » 06:00
09/22/20
09/22
06:00
09/22/20
06:00
ISNPY

Intesa Sanpaolo

/

+

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ISNPY Intesa Sanpaolo
/

+

ISNPY Intesa Sanpaolo
/

+

08/11/20 Berenberg
Intesa Sanpaolo price target raised to EUR 1.50 from EUR 1.30 at Berenberg
08/07/20 UBS
Intesa Sanpaolo upgraded to Buy from Neutral at UBS
08/05/20 AlphaValue
Intesa Sanpaolo upgraded to Add from Sell at AlphaValue
07/31/20 JPMorgan
Intesa Sanpaolo reinstated with an Overweight at JPMorgan
ISNPY Intesa Sanpaolo
/

+

Downgrade
Stifel downgrades Illumina to Hold after 'massively dilutive' deal » 06:00
09/22/20
09/22
06:00
09/22/20
06:00
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Stifel analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
05:02 Today Piper Sandler
Piper stays on sidelines after Illumina acquisition of Grail
09/21/20 JPMorgan
Illumina downgraded to Neutral after deal for Grail at JPMorgan
09/21/20 JPMorgan
Illumina downgraded to Neutral from Overweight at JPMorgan
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Periodicals
Exxon Mobil North Sea assets draw Sinopec, EnQuest as suitors, Bloomberg says » 05:59
09/22/20
09/22
05:59
09/22/20
05:59
XOM

Exxon Mobil

$36.43 /

-0.75 (-2.02%)

, SNP

Sinopec

$42.29 /

-0.76 (-1.77%)

, ENQUF

EnQuest

$0.00 /

+ (+0.00%)

Exxon Mobil's (XOM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

09/11/20 Standpoint Research
Exxon Mobil upgraded to Buy from Hold at Standpoint Research
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 MKM Partners
Exxon Mobil initiated with a Buy at MKM Partners
09/09/20 MKM Partners
Exxon Mobil initiated with a Buy at MKM Partners
SNP Sinopec
$42.29 /

-0.76 (-1.77%)

03/03/20 JPMorgan
Sinopec downgraded to Neutral from Overweight at JPMorgan
02/12/20 Citi
Sinopec downgraded to Neutral from Buy at Citi
02/04/20 Credit Suisse
Sinopec downgraded to Underperform from Neutral at Credit Suisse
01/13/20 BofA
Sinopec downgraded earlier to Neutral from Buy at BofA
ENQUF EnQuest
$0.00 /

+ (+0.00%)

05/06/20 Barclays
EnQuest price target lowered to 10 GBp from 12 GBp at Barclays
04/28/20 Jefferies
EnQuest upgraded to Hold from Underperform at Jefferies
04/01/20 Barclays
EnQuest downgraded to Equal Weight from Overweight at Barclays
03/16/20 RBC Capital
EnQuest downgraded to Underperform from Sector Perform at RBC Capital
XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

SNP Sinopec
$42.29 /

-0.76 (-1.77%)

XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

XOM Exxon Mobil
$36.43 /

-0.75 (-2.02%)

Initiation
APi Group initiated with an Overweight at Barclays » 05:57
09/22/20
09/22
05:57
09/22/20
05:57
APG

APi Group

$13.81 /

-0.125 (-0.90%)

Barclays analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APG APi Group
$13.81 /

-0.125 (-0.90%)

APG APi Group
$13.81 /

-0.125 (-0.90%)

08/17/20 UBS
APi Group price target raised to $20 from $15 at UBS
06/24/20 Baird
APi Group initiated with an Outperform at Baird
06/23/20 Baird
APi Group initiated with an Outperform at Baird
06/03/20 Citi
APi Group price target raised to $14 from $12 at Citi
APG APi Group
$13.81 /

-0.125 (-0.90%)

Upgrade
Safran upgraded to Overweight from Equal Weight at Barclays » 05:55
09/22/20
09/22
05:55
09/22/20
05:55
SAFRY

Safran

$0.00 /

+ (+0.00%)

Barclays analyst Milene…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAFRY Safran
$0.00 /

+ (+0.00%)

08/11/20 Berenberg
Safran price target raised to EUR 92 from EUR 80 at Berenberg
07/31/20 JPMorgan
Safran price target lowered to EUR 68 from EUR 70 at JPMorgan
07/27/20 JPMorgan
Safran price target raised to EUR 70 from EUR 64 at JPMorgan
07/14/20 UBS
Safran price target raised to EUR 91 from EUR 75 at UBS
Upgrade
Bernstein upgrades Amazon.com to Outperform after 16% pullback » 05:53
09/22/20
09/22
05:53
09/22/20
05:53
AMZN

Amazon.com

$2,962.00 /

+9.47 (+0.32%)

Bernstein analyst Mark…

Bernstein analyst Mark Shmulik upgraded Amazon.com to Outperform from Market Perform with an unchanged price target of $3,400. Recent work suggests that Amazon is positioned to increase its "dominant share position" when the return to physical stores occurs, Shmulik tells investors in a research note. Further, Amazon has also "quietly made substantial inroads" into grocery and shopping verticals, adds the analyst. Amazon.com shares have sold off 16% in the last couple of weeks, creating an "attractive entry point," says Shmulik. The analyst also believes the company is well positioned to benefit from the "permanent pull forward" in the hyper-scale cloud market.

ShowHide Related Items >><<
AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

05:20 Today Bernstein
Amazon.com upgraded to Outperform from Market Perform at Bernstein
09/20/20 Citi
Kornit Digital upgraded to Buy from Neutral at Citi
09/18/20 RBC Capital
Amazon.com's logistics network underappreciated by investors, says RBC Capital
09/16/20 Morgan Stanley
FedEx price target raised to $250 from $110 at Morgan Stanley
AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

AMZN Amazon.com
$2,962.00 /

+9.47 (+0.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.